Literature DB >> 14484792

The effect of a serotonin antagonist (UML 491) in carcinoid disease.

W S PEART, J I ROBERTSON.   

Abstract

Entities:  

Keywords:  LYSERGIC ACID DIETHYLAMIDE/related compounds; MALIGNANT CARCINOID SYNDROME/therapy

Mesh:

Substances:

Year:  1961        PMID: 14484792     DOI: 10.1016/s0140-6736(61)90846-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Motor responses of human gastrointestinal tract to 5-hydroxytryptamine in vivo and in vitro.

Authors:  J J Misiewicz; S L Waller; M Eisner
Journal:  Gut       Date:  1966-06       Impact factor: 23.059

2.  Effect of methyldopa in carcinoid disease.

Authors:  G I NICHOLSON; R O IRVINE
Journal:  Br Med J       Date:  1962-10-13

Review 3.  Serotonin and vascular disease: a survey.

Authors:  J I Robertson
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

Review 4.  Diarrhoea: mechanisms and treatment.

Authors:  T S Low-Beer; A E Read
Journal:  Gut       Date:  1971-12       Impact factor: 23.059

5.  Forgotten bradykinin?

Authors:  R W Griffiths
Journal:  Br Med J       Date:  1972-05-27

6.  The release of biologically active substances from isolated lungs by 5-hydroxytryptamine and tryptamine.

Authors:  V A Alabaster; Y S Bakhle
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

7.  Surgical approaches and drug treatment in the carcinoid syndrome.

Authors: 
Journal:  Br Med J       Date:  1978-06-17

8.  The effect of 5-hydroxytryptamine on the human colon in vivo and in vitro.

Authors:  J J Misiewicz; S L Waller
Journal:  Proc R Soc Med       Date:  1967-03

9.  Effects of serotonin on rat ileocolonic transit and fluid transfer in vivo: possible mechanisms of action.

Authors:  L Oosterbosch; M von der Ohe; M A Valdovinos; L J Kost; S F Phillips; M Camilleri
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

Review 10.  Carcinoid syndrome and serotonin: therapeutic effects of ketanserin.

Authors:  J I Robertson
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.